Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression

能量平衡相关激素

基本信息

  • 批准号:
    8138667
  • 负责人:
  • 金额:
    $ 63.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-26 至 2013-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Recent evidence has confirmed that positive energy balance, as estimated by obesity, strongly influences prostate carcinogenesis. However, the complexity of how energy balance influences, and is influenced, by various metabolic hormones and sympathetic nervous system activity (SNS) adds considerable complexity to the role of energy balance for this cancer. Further, the influences of energy balance may differ for prostate cancer incidence and progression. A third complicating factor is that there may be distinct etiologies for early- onset and late-onset prostate cancers. We propose three distinct patterns, suggested by our preliminary data and other studies, whereby energy balance related variables influence prostate cancer: Pattern 1: Metabolic alterations associated with obesity and lack of physical activity, including high insulin and leptin, and low adiponectin levels, increase risk of prostate cancer progression. Further, the low testosterone levels associated with obesity may contribute to more poorly differentiated cancers and thus a worse prognosis. Pattern 2: Higher insulin-like growth factor (IGF-1) levels influence progression of well- to moderately-well differentiated prostate cancers, whereas cancers that have molecular alterations in the IGF-1 signaling pathway and hence upregulated IGF-1 signaling are relatively unresponsive to circulating IGF-1 levels. Pattern 3: Younger men with an inherent metabolic phenotype related to SNS activity that disassociates high energy intake from weight gain and which is associated with chronic prostatitis/chronic pelvic pain syndrome prostatitis are at increased risk of prostate cancer. We will address these three patterns whereby energy balance may influence prostate cancer risk in the Health Professionals Follow-up Study (HPFS), a cohort of the 47,000 men free of cancer at baseline in 1986. We project 6,085 new cases of prostate cancer by 2010, including 668 fatal cases, with tumor blocks from over 1,900 prostatectomy cases. The sources of the exposure data in the HPFS are questionnaire, including diet, anthropometric measures, activity, medication use, and plasma samples. The outcome data will be based on (1) medical record and pathology report review, and (2) tissue block markers that correlate with disease progression. Stratified analysis and multivariate analysis will be used to control for confounding factors. Our ultimate goal is to better understand how body weight, and related dietary and other modifiable factors, influence prostate carginogenesis at various stages. PUBLIC HEALTH RELEVANCE: Our preliminary data and other data suggest that energy balance-related variables influence prostate cancer. To help reduce the apparent inconsistencies in the literature for energy balance and prostate cancer risk, we hypothesize three distinct patterns whereby energy balance variables may influence prostate cancer risk. These three patterns would also help explain some of the apparent age patterns of prostate cancer epidemiology. We propose to study these patterns in the Health Professionals Follow-up Study (HPFS), a cohort of the 47,000 men free of cancer at baseline in 1986. We project 6,085 new cases of prostate cancer by 2010, including 668 fatal cases, with tumor blocks from over 1,900 prostatectomy cases. Our ultimate goal is to better understand how body weight, and related dietary and other modifiable factors, influence prostate carcinogenesis at various stages with a focus on prevention of morbidity and mortality from these risk factors.
描述(由申请人提供):最近的证据已经证实,正能量平衡,如通过肥胖估计的,强烈影响前列腺癌的发生。然而,能量平衡如何影响以及如何受各种代谢激素和交感神经系统活动(SNS)影响的复杂性,给这种癌症的能量平衡作用增加了相当大的复杂性。此外,能量平衡的影响对于前列腺癌的发病率和进展可能不同。第三个复杂因素是早发性和晚发性前列腺癌可能有不同的病因。根据我们的初步数据和其他研究,我们提出了三种不同的模式,即能量平衡相关变量影响前列腺癌:模式1:与肥胖和缺乏体力活动相关的代谢改变,包括高胰岛素和瘦素,以及低脂联素水平,增加前列腺癌进展的风险。此外,与肥胖相关的低睾酮水平可能导致更多的低分化癌症,从而导致更差的预后。模式二:较高的胰岛素样生长因子(IGF-1)水平影响高度分化至中度分化的前列腺癌的进展,而在IGF-1信号传导途径中具有分子改变并因此上调IGF-1信号传导的癌症对循环IGF-1水平相对无反应。模式三:具有与SNS活动相关的固有代谢表型的年轻男性,其将高能量摄入与体重增加分离,并且与慢性前列腺炎/慢性骨盆疼痛综合征前列腺炎相关,其患前列腺癌的风险增加。我们将在健康专业人员随访研究(HPFS)中讨论这三种能量平衡可能影响前列腺癌风险的模式,该研究包括1986年基线时无癌症的47,000名男性。到2010年,我们预计将有6,085例新的前列腺癌病例,包括668例死亡病例,其中1,900多例前列腺切除术病例的肿瘤块。HPFS中暴露数据的来源是问卷调查,包括饮食、人体测量、活动、药物使用和血浆样本。结局数据将基于(1)病历和病理学报告审查,以及(2)与疾病进展相关的组织块标志物。分层分析和多变量分析将用于控制混杂因素。我们的最终目标是更好地了解体重,相关的饮食和其他可改变的因素,如何影响前列腺在不同阶段的carginogenesis。公共卫生相关性:我们的初步数据和其他数据表明,能量平衡相关的变量影响前列腺癌。为了帮助减少文献中能量平衡和前列腺癌风险的明显不一致,我们假设能量平衡变量可能影响前列腺癌风险的三种不同模式。这三种模式也有助于解释前列腺癌流行病学的一些明显的年龄模式。我们建议在卫生专业人员随访研究(HPFS)中研究这些模式,这是一个在1986年基线时无癌症的47,000名男性的队列。到2010年,我们预计将有6,085例新的前列腺癌病例,包括668例死亡病例,其中1,900多例前列腺切除术病例的肿瘤块。我们的最终目标是更好地了解体重,相关的饮食和其他可改变的因素,如何影响前列腺癌在不同阶段的发病率和死亡率,重点是预防这些危险因素。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDWARD GIOVANNUCCI其他文献

EDWARD GIOVANNUCCI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDWARD GIOVANNUCCI', 18)}}的其他基金

Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk
肥胖和消化道癌症风险中代谢失调的解码机制
  • 批准号:
    10504203
  • 财政年份:
    2022
  • 资助金额:
    $ 63.35万
  • 项目类别:
Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk
肥胖和消化道癌症风险中代谢失调的解码机制
  • 批准号:
    10707361
  • 财政年份:
    2022
  • 资助金额:
    $ 63.35万
  • 项目类别:
Association between pre-diagnosis hepatic fat infiltration and risk of liver metastasis and mortality in a large cohort of stage I-III colorectal cancer survivors
大量 I-III 期结直肠癌幸存者中诊断前肝脂肪浸润与肝转移风险和死亡率之间的关联
  • 批准号:
    10295142
  • 财政年份:
    2022
  • 资助金额:
    $ 63.35万
  • 项目类别:
Association between pre-diagnosis hepatic fat infiltration and risk of liver metastasis and mortality in a large cohort of stage I-III colorectal cancer survivors
大量 I-III 期结直肠癌幸存者中诊断前肝脂肪浸润与肝转移风险和死亡率之间的关联
  • 批准号:
    10709469
  • 财政年份:
    2022
  • 资助金额:
    $ 63.35万
  • 项目类别:
Impact of screening and diagnostic intensity on the study of prostate cancer epidemiology
筛查和诊断强度对前列腺癌流行病学研究的影响
  • 批准号:
    9811066
  • 财政年份:
    2019
  • 资助金额:
    $ 63.35万
  • 项目类别:
Colorectal Cancer
结直肠癌
  • 批准号:
    7786694
  • 财政年份:
    2010
  • 资助金额:
    $ 63.35万
  • 项目类别:
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression
能量平衡相关激素
  • 批准号:
    8301690
  • 财政年份:
    2008
  • 资助金额:
    $ 63.35万
  • 项目类别:
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression
能量平衡相关激素
  • 批准号:
    7693712
  • 财政年份:
    2008
  • 资助金额:
    $ 63.35万
  • 项目类别:
A Prospective Study of Diet and Prostate Cancer
饮食与前列腺癌的前瞻性研究
  • 批准号:
    7191213
  • 财政年份:
    2006
  • 资助金额:
    $ 63.35万
  • 项目类别:
DIET, HORMONES, AND RISK OF COLORECTAL CANCER
饮食、激素和结直肠癌的风险
  • 批准号:
    7072371
  • 财政年份:
    2004
  • 资助金额:
    $ 63.35万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.35万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了